Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Chemotherapy Regimens With or Without SBRT for Borderline Resectable Pancreatic Cancer
NCT03777462Phase 2Unknown
- Sponsor
- Changhai Hospital
- Start
- Apr 2019
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur in pancreatic cancer (PC), sponsored by Changhai Hospital. Status: unknown.
02
Drugs
tegafur
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT03777462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03777462.